ArticleESMO open2026

Outcomes of immune-checkpoint inhibitor rechallenge in metastatic clear-cell renal cell carcinoma: results from a global real-world evidence study.

A Cigliola et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.